441 related articles for article (PubMed ID: 8419816)
1. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.
Hentschel E; Brandstätter G; Dragosics B; Hirschl AM; Nemec H; Schütze K; Taufer M; Wurzer H
N Engl J Med; 1993 Feb; 328(5):308-12. PubMed ID: 8419816
[TBL] [Abstract][Full Text] [Related]
2. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
[TBL] [Abstract][Full Text] [Related]
3. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.
Schütze K; Hentschel E; Hirschl AM
Hepatogastroenterology; 1999; 46(28):2358-62. PubMed ID: 10521998
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of omeprazole combined with antibiotics for Helicobacter pylori eradication and duodenal ulcer recurrence.
Lazzaroni M; Maconi G; Bargiggia S; Minguzzi M; Bianchi Porro G
Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):117-9. PubMed ID: 7712301
[TBL] [Abstract][Full Text] [Related]
5. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study.
Lai KC; Hui WM; Wong WM; Wong BC; Hu WH; Ching CK; Lam SK
Am J Gastroenterol; 2000 Sep; 95(9):2225-32. PubMed ID: 11007222
[TBL] [Abstract][Full Text] [Related]
7. Five-day bismuth-free triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse.
Coelho LG; Passos MC; Chausson Y; Castro Lde P
Am J Gastroenterol; 1991 Aug; 86(8):971-5. PubMed ID: 1858763
[TBL] [Abstract][Full Text] [Related]
8. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer].
Ocaña Andrade E; Espinosa Soberanes JA; Mares Zambrano MA; Rosete Reyes A
Rev Gastroenterol Mex; 1998; 63(4):182-6. PubMed ID: 10319667
[TBL] [Abstract][Full Text] [Related]
10. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
11. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
12. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
[TBL] [Abstract][Full Text] [Related]
13. [Eradication of Helicobacter pylori. Effectiveness of a combination of ranitidine and metronidazole/roxithromycin].
Stölzle L
Fortschr Med; 1994 Sep; 112(26):363-4. PubMed ID: 7959514
[TBL] [Abstract][Full Text] [Related]
14. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
Tepes B; Kavcic B; Gubina M; Krizman I
Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence. Results of a multicentric double-blind randomized trial.
Sobhani I; Chastang C; De Korwin JD; Lamouliatte H; Mégraud F; Guerre J; Elouaer-Blanc L
Gastroenterol Clin Biol; 1995 Mar; 19(3):252-8. PubMed ID: 7781936
[TBL] [Abstract][Full Text] [Related]
16. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
[TBL] [Abstract][Full Text] [Related]
17. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
Rosengren H; Polson RJ
Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
[TBL] [Abstract][Full Text] [Related]
18. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
[TBL] [Abstract][Full Text] [Related]
19. Ranitidine in a twice daily triple therapy regimen for the eradication of Helicobacter pylori.
Harris A
Eur J Gastroenterol Hepatol; 1997 May; 9(5):544. PubMed ID: 9187893
[No Abstract] [Full Text] [Related]
20. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
